GB957392A - 16ª-hydroxy-steroids - Google Patents
16ª-hydroxy-steroidsInfo
- Publication number
- GB957392A GB957392A GB26865/62A GB2686562A GB957392A GB 957392 A GB957392 A GB 957392A GB 26865/62 A GB26865/62 A GB 26865/62A GB 2686562 A GB2686562 A GB 2686562A GB 957392 A GB957392 A GB 957392A
- Authority
- GB
- United Kingdom
- Prior art keywords
- steroids
- hydroxy
- methyl
- general formula
- active ingredient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P33/00—Preparation of steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P33/00—Preparation of steroids
- C12P33/12—Acting on D ring
- C12P33/14—Hydroxylating at 16 position
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
The invention comprises steroids of the general formula: <FORM:0957392/C2/1> wherein R represents hydrogen or methyl and R1 represents the acyl radical of an aliphatic, cycloaliphatic or aromatic acid having from 1 to 9 carbon atoms, and a process for the preparation of 16a -hydroxy-steroids by treating steroid compounds having a methylenic group at the 16-position with a culture produced by growing the microorganisms Nocardia italica or a mutant thereof in a sterilized liquid nutritional medium containing assimilable sources of carbon and nitrogen at from 24 to 30 DEG C. at a pH of from 6 to 7.5. Therapeutic compositions having anticancer activity contain as the active ingredient steroids of the above general formula and a therapeutically acceptable carrier for example, an injectable carrier, or contain as the active ingredient 16a -hydroxy-17a -methyl-19-nor-testosterone and a therapeutically acceptable injectable carrier. Specifications 848,288 and 888,665 are referred to.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT1322761 | 1961-07-17 | ||
IT508862 | 1962-03-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB957392A true GB957392A (en) | 1964-05-06 |
Family
ID=26325638
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB26865/62A Expired GB957392A (en) | 1961-07-17 | 1962-07-12 | 16ª-hydroxy-steroids |
Country Status (4)
Country | Link |
---|---|
DK (1) | DK104347C (en) |
ES (1) | ES279287A1 (en) |
FR (1) | FR2179M (en) |
GB (1) | GB957392A (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE439586B (en) * | 1975-09-05 | 1985-06-24 | Kanebo Ltd | SET TO PREPARE A STABLE PHARMACEUTICAL DRY PREPARATION OF AN ALKALIMETAL SALT OF DEHYDROEPIANDROSTERON SULPHATE |
-
1962
- 1962-07-12 GB GB26865/62A patent/GB957392A/en not_active Expired
- 1962-07-16 ES ES279287A patent/ES279287A1/en not_active Expired
- 1962-07-16 FR FR904066A patent/FR2179M/en active Active
- 1962-07-16 DK DK318262AA patent/DK104347C/en active
Also Published As
Publication number | Publication date |
---|---|
DK104347C (en) | 1966-05-09 |
ES279287A1 (en) | 1963-05-01 |
FR2179M (en) | 1963-12-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2131207T3 (en) | AMIDAS DERIVATIVES OF VALPROIC ACID AND 2-VALPROENOIC ACID AND ITS USE AS ANTICONVULSIVES. | |
HU913396D0 (en) | Process for the production of azasteroide compounds and medical preparations containing them as active agents | |
GB957392A (en) | 16ª-hydroxy-steroids | |
ES8600224A1 (en) | Carbamyloxybenzhydrole derivatives, process for their preparation and pharmaceutical compositions containing them. | |
GB1512101A (en) | Piperazinopyrimidines process for their preparation and use | |
US2915434A (en) | 16-fluoro-3-keto-17beta-(beta-hydroxy-propanoyl)-delta4-androstenes and derivatives thereof | |
ES2013806A6 (en) | Derivatives of 19-norprogesterone, their preparation and their use. | |
DE3371787D1 (en) | 17-alpha-pregn-4-ene-3-oxo-21-carboxylic acid esters, process for the preparation thereof, and use thereof as medicinal agents | |
GB966822A (en) | New quaternary ammonium derivatives and process for their preparation | |
GB1424147A (en) | Agents for regulating plant growth | |
GB1456550A (en) | Zootechnical and veterinary compositions | |
GB891825A (en) | A-nor-steroids | |
HU174772B (en) | Process for producing pharmaceutically active acetic acid derivatives | |
GB929743A (en) | Improvements in or relating to cyclopentanophenanthrene compounds | |
GB853293A (en) | Cyclopentanophenanthrene derivatives and process for the preparation thereof | |
GB924368A (en) | Steroid compounds | |
GB849755A (en) | Pharmaceutical preparations comprising ª‡-dialkylamino-propiophenones | |
GB908976A (en) | Process for the manufacture of í~-dehydrosteroids | |
GB915780A (en) | 21-methylene-progesterone derivatives and compositions thereof | |
GB961101A (en) | Steroid compounds | |
GB1261981A (en) | 4-oxa- and 4-oxa-a-homo-steroids | |
GB938440A (en) | Improvements in steroid processes | |
TH14770EX (en) | “A new ingredient with Nomegestral as the main ingredient. And the process of preparing these substances " | |
GB835515A (en) | Preparation of new 9-hydroxy-4-pregnenes | |
GB1456528A (en) | Pharmaceutical preparations and packs based on androst-3-en -17-o- and esters thereof |